TELA Bio, Inc. (TELA) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	79.9M	80.3M	69.3M	58.5M	41.4M
Cost of Revenue	25.7M	25.9M	22.8M	18.3M	14.4M
Gross Profit	54.2M	54.3M	46.5M	40.1M	27.0M
Operating Expenses
R&D Expense	9.5M	9.2M	8.8M	9.6M	8.9M
SG&A Expense	78.7M	78.9M	79.4M	74.6M	57.1M
General & Admin Expense	16.0M	15.7M	14.7M	14.9M	13.9M
Selling & Marketing Expense	62.7M	63.2M	64.6M	59.7M	43.3M
Other Expenses	—	—	(7.6M)	—	—
Total Operating Expenses	88.2M	88.1M	80.6M	84.2M	66.1M
Cost and Expenses	113.9M	114.0M	103.4M	102.5M	80.4M
Operating Income (EBIT)	(34.0M)	(33.8M)	(34.1M)	(44.1M)	(39.0M)
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	2.9M	5.2M	5.3M	5.2M	4.1M
Net Interest Income	(2.9M)	(5.2M)	(5.3M)	(5.2M)	(4.1M)
Other Non-Op Income/Expense	(6.9M)	(4.8M)	(3.9M)	(2.6M)	(5.3M)
Non-Operating Income (excl Interest)	(64.0K)	(399.0K)	(1.4M)	(2.6M)	1.2M
EBT (Pre-Tax Income)	(40.9M)	(38.6M)	(38.0M)	(46.7M)	(44.3M)
Income Tax Expense	265.0K	230.0K	(144.0K)	—	—
Bottom Line
Net Income	(41.2M)	(38.8M)	(37.8M)	(46.7M)	(44.3M)
Earnings from Cont. Ops	(41.2M)	(38.8M)	(37.8M)	(46.7M)	(44.3M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(41.2M)	(38.8M)	(37.8M)	(46.7M)	(44.3M)
Per Share
Basic EPS	($0.77)	($0.83)	($1.33)	($2.04)	($2.73)
Diluted EPS	($0.77)	($0.83)	($1.33)	($2.04)	($2.73)
Revenue Per Share	$1.39	$1.71	$2.43	$2.56	$2.55
Shares
Basic Shares Outstanding	57.4M	46.9M	28.5M	22.9M	16.3M
Diluted Shares Outstanding	57.4M	46.9M	28.5M	22.9M	16.3M
Profitability Metrics
EBITDA	(33.1M)	(32.3M)	(31.7M)	(40.6M)	(39.1M)
D&A	832.0K	1.0M	1.0M	808.0K	1.2M
EBIT	(33.9M)	(33.4M)	(32.7M)	(41.4M)	(40.2M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026